http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111743890-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6655263ba4852e71280f7529b0065f3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351 |
| filingDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e86c01d5556b5dc7d8836c6155d3607 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d76a050eee6387f76cb4b780297e4eb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d339c6047c42b1f3290032bc8617ec08 |
| publicationDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111743890-A |
| titleOfInvention | Use of aquamarin or its derivatives |
| abstract | The present invention relates to the technical field of medicine, in particular to the use of aquamarin or its derivatives. The study of the present invention shows that alimycin or its derivatives can inhibit the increase of cytokine levels caused by CRS, inhibit the increase of body temperature caused by CRS, maintain the body weight of animals receiving adoptive immunotherapy, and relieve and/or treat CRS. Compared with the solution in the prior art in which the antibody drug can only inhibit the activity of one cytokine, the technical solution of the present invention has a lower cost, can simultaneously inhibit the activity of multiple cytokines, and has a significant effect. |
| priorityDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.